Cargando…
Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations
Hsp70 is a promising anti-cancer target. Our JG-98 series of Hsp70 inhibitors show anti-cancer activities affecting both cancer cells and tumor-associated macrophages. They disrupt Hsp70 interaction with a co-chaperone Bag3 and affect signaling pathways important for cancer development. Due to a pri...
Autores principales: | Yaglom, Julia A., Wang, Yongmei, Li, Amy, Li, Zhenghu, Monti, Stephano, Alexandrov, Ilya, Lu, Xiongbin, Sherman, Michael Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813176/ https://www.ncbi.nlm.nih.gov/pubmed/29445088 http://dx.doi.org/10.1038/s41598-017-14900-0 |
Ejemplares similares
-
Author Correction: Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations
por: Yaglom, Julia A., et al.
Publicado: (2018) -
Inhibitors of HSP90 in melanoma
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019) -
The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
por: Lackie, Rachel E., et al.
Publicado: (2017) -
Functional Analysis of Hsp70 Inhibitors
por: Schlecht, Rainer, et al.
Publicado: (2013) -
17-DMAG, an HSP90 Inhibitor, Ameliorates Multiple Organ Dysfunction Syndrome via Induction of HSP70 in Endotoxemic Rats
por: Wang, Yi-Li, et al.
Publicado: (2016)